New treatment option for endometrial cancer shows promise in phase II trial

The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.

FDA updates label of 33-year-old cancer drug with new dose and warning

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 21, 2024

Alzheimer’s Patients May Gain Months of Independent Living With Treatment

A model estimated how long anti-amyloid drugs might extend independent living for Alzheimer’s patients. Patients with low baseline impairment could gain 10-13 months of independence

February 20, 2025

FDA unveils new rare disease pilot program to increase agency-sponsor communications

The FDA on Friday unveiled new details around a rare disease pilot program that seeks to increase rapid, ad-hoc communications between six sponsors working on

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.